1. Home
  2. BIO vs CX Comparison

BIO vs CX Comparison

Compare BIO & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • CX
  • Stock Information
  • Founded
  • BIO 1952
  • CX 1906
  • Country
  • BIO United States
  • CX Mexico
  • Employees
  • BIO N/A
  • CX N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • CX Building Materials
  • Sector
  • BIO Industrials
  • CX Industrials
  • Exchange
  • BIO Nasdaq
  • CX Nasdaq
  • Market Cap
  • BIO 9.1B
  • CX 7.6B
  • IPO Year
  • BIO N/A
  • CX 1999
  • Fundamental
  • Price
  • BIO $323.65
  • CX $5.52
  • Analyst Decision
  • BIO Strong Buy
  • CX Buy
  • Analyst Count
  • BIO 4
  • CX 6
  • Target Price
  • BIO $411.00
  • CX $7.87
  • AVG Volume (30 Days)
  • BIO 211.4K
  • CX 12.8M
  • Earning Date
  • BIO 10-30-2024
  • CX 10-28-2024
  • Dividend Yield
  • BIO N/A
  • CX 0.77%
  • EPS Growth
  • BIO N/A
  • CX 212.33
  • EPS
  • BIO N/A
  • CX 0.03
  • Revenue
  • BIO $2,580,209,000.00
  • CX $17,249,067,000.00
  • Revenue This Year
  • BIO N/A
  • CX $5.48
  • Revenue Next Year
  • BIO $3.61
  • CX $3.14
  • P/E Ratio
  • BIO N/A
  • CX $17.45
  • Revenue Growth
  • BIO N/A
  • CX 5.20
  • 52 Week Low
  • BIO $262.12
  • CX $5.00
  • 52 Week High
  • BIO $387.99
  • CX $9.27
  • Technical
  • Relative Strength Index (RSI)
  • BIO 39.02
  • CX 43.32
  • Support Level
  • BIO $306.42
  • CX $5.32
  • Resistance Level
  • BIO $387.99
  • CX $5.56
  • Average True Range (ATR)
  • BIO 12.82
  • CX 0.22
  • MACD
  • BIO -5.89
  • CX 0.01
  • Stochastic Oscillator
  • BIO 21.17
  • CX 35.04

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CX Cemex S.A.B. de C.V. Sponsored ADR

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services.

Share on Social Networks: